<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36508159</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8253</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Neurology and therapy</Title><ISOAbbreviation>Neurol Ther</ISOAbbreviation></Journal><ArticleTitle>Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic.</ArticleTitle><Pagination><StartPage>329</StartPage><EndPage>332</EndPage><MedlinePgn>329-332</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40120-022-00426-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vink</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1079-5647</Identifier><AffiliationInfo><Affiliation>Independent Researcher, Amsterdam, The Netherlands. markvink.md@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grande</LastName><ForeName>Tilman</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Private Practice, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohl</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9514-8910</Identifier><AffiliationInfo><Affiliation>Institute of Precision Medicine, Furtwangen University, Furtwangen im Schwarzwald, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Neurol Ther</MedlineTA><NlmUniqueID>101637818</NlmUniqueID><ISSNLinking>2193-6536</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Neurol Ther. 2022 Dec;11(4):1637-1657. doi: 10.1007/s40120-022-00395-z</RefSource><PMID Version="1">36028604</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36508159</ArticleId><ArticleId IdType="pmc">PMC9744047</ArticleId><ArticleId IdType="doi">10.1007/s40120-022-00426-9</ArticleId><ArticleId IdType="pii">10.1007/s40120-022-00426-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischer M, Szepanowski F, Tovar M, et al. Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. Neurol Ther. 2022;11:1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType="pmc">PMC9417089</ArticleId><ArticleId IdType="pubmed">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;23(12):698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>National Cancer Institute, National Institutes of Health. Prospective cohort study. Search NCI's dictionary of cancer terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prospective-cohort-study. Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Campen C, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina. 2022;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161(1):54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 Pandemic in the Italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health. 2020;17(11):4151. doi: 10.3390/ijerph17114151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17114151</ArticleId><ArticleId IdType="pmc">PMC7312976</ArticleId><ArticleId IdType="pubmed">32532077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/ CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina (Mex) 2021;57(5):418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. International statistical classification of diseases and related health problems, 10th revision, fifth edition. 2016. https://apps.who.int/iris/handle/10665/246208. Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>Institute of Medicine (IOM). Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness; National Academies Press: Washington, DC, USA, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutch Health Council. To the President of the Lower House of the States-General No. 2018, The Hague 19 March Health Council|No. 2018/07. 2018. https://huisartsvink.files.wordpress.com/2021/01/gezondheidsraad-kernadvies_me_cvs.pdf. Accessed 19 Sep 2022.</Citation></Reference><Reference><Citation>The National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE Guideline [NG206] 29 October 2021. https://www.nice.org.uk/guidance/ng206. Accessed 19 Sep 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.</Citation></Reference><Reference><Citation>Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124. doi: 10.1371/journal.pmed.0020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>